Publications by authors named "G Ousler"

Claim this Profile
A
Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials.
John D Rodriguez, Samantha Kerti, Adam Hamm, George W Ousler, Ethan Bensinger

Clin Ophthalmol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease.
Robert O Baratta, Eric Schlumpf, Brian J Del Buono, Shawn DeLorey, George Ousler

Ophthalmol Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease.
David Evans, Kenneth Kenyon, George Ousler, Michael Watson, Patrick Vollmer

J Ocul Pharmacol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1).
David L Wirta, Michelle Senchyna, Amber E Lewis, David G Evans, Eugene B McLaurin, George W Ousler

Ocul Surf· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China.
Yanling Dong, Shuang Wang, Lin Cong, Ting Zhang, Jun Cheng, George W Ousler

Int Ophthalmol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis